Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of General Virology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/vir.0.83449-0PMID 18343835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Polymerase Activity in Avian and Mammalian Cells Determines Host Range of Influenza Virus

  2007cited by this paper
• Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

  2007cited by this paper
• Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection Models

  2007cited by this paper
• In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile Virus

  2007cited by this paper
• Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers

  2006influential reference
• Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

  2006cited by this paper
• VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice

  2006cited by this paper
• Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

  2006cited by this paper
• Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry Site

  2006cited by this paper
• The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host.

  2005influential reference
• Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species

  2005cited by this paper
• Oseltamivir resistance during treatment of influenza A (H5N1) infection.

  2005cited by this paper
• Avian flu: Isolation of drug-resistant H5N1 virus

  2005cited by this paper
• Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.

  2004cited by this paper
• Use of siRNAs to prevent and treat influenza virus infection.

  2004cited by this paper
• Protection against lethal influenza virus challenge by RNA interference in vivo.

  2004cited by this paper
• The PA Subunit Is Required for Efficient Nuclear Accumulation of the PB1 Subunit of the Influenza A Virus RNA Polymerase Complex

  2004cited by this paper
• A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells

  2004cited by this paper
• Inhibition of influenza virus production in virus-infected mice by RNA interference.

  2004cited by this paper
• Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.

  2004cited by this paper
• Orthomyxovirus replication, transcription, and polyadenylation.

  2004cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

  2004cited by this paper
• RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription

  2003cited by this paper
• Influenza-virus-induced signaling cascades: targets for antiviral therapy?

  2003cited by this paper
• Cytokines and their role in lymphoid development, differentiation and homeostasis

  2002cited by this paper
• A Single Amino Acid Mutation in the PA Subunit of the Influenza Virus RNA Polymerase Inhibits Endonucleolytic Cleavage of Capped RNAs

  2002cited by this paper
• Thrombopoietin: the novel hepatic hormone.

  2002cited by this paper
• Antisense therapy of influenza.

  2001cited by this paper
• Inhibitory Effect of Modified 5′-Capped Short RNA Fragments on Influenza Virus RNA Polymerase Gene Expression

  2001cited by this paper
• Interleukin-4 and IFN-gamma Differentially Stimulate Macrophage Chemoattractant Protein-1 (MCP-1) and Eotaxin Production by Intestinal Epithelial Cells

  2000cited by this paper
• Resistance of influenza viruses to neuraminidase inhibitors--a review.

  2000cited by this paper
• Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans

  2000cited by this paper
• Measurement of thrombopoietic levels: clinical and biological relationships

  2000cited by this paper
• Morpholino antisense oligomers: the case for an RNase H-independent structural type.

  1999cited by this paper
• Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

  1998cited by this paper
• Role of Interleukin-12 in Primary Influenza Virus Infection

  1998cited by this paper
• Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P.

  1998cited by this paper
• A Specificity Comparison of Four Antisense Types: Morpholino, 2′-O-Methyl RNA, DNA, and Phosphorothioate DNA

  1997cited by this paper
• Functions of IL-4 and control of its expression.

  1997cited by this paper
• Morpholino Antisense Oligomers: Design, Preparation, and Properties

  1997cited by this paper
• avian influenza virus

  1997cited by this paper
• Promoter elements in the influenza vRNA terminal structure.

  1996cited by this paper
• Generation of seal influenza virus variants pathogenic for chickens, because of hemagglutinin cleavage site changes

  1990cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowncited by this paper

• RNA viruses: from RNA processing and interaction mechanisms to new prevention and control strategies

  2025cites this paper
• Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA

  2024cites this paper
• Antisense oligonucleotides: a promising therapeutic option against infectious diseases

  2023cites this paper
• Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives

  2023cites this paper
• Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections

  2023cites this paper
• Antisense oligonucleotide: A promising therapeutic option to beat COVID‐19

  2021cites this paper
• Effective Inhibition of Newly Emerged A/H7N9 Virus with Oligonucleotides Targeted to Conserved Regions of the Virus Genome

  2021cites this paper
• Pronounced therapeutic potential of oligonucleotides fixed on inorganic nanoparticles against highly pathogenic H5N1 influenza A virus in vivo.

  2021cites this paper
• Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers

  2020cites this paper
• Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting

  2020cites this paper
• Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino-oligomers

  2020cites this paper
• Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting

  2020cites this paper
• TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets

  2020cites this paper
• Peptide Conjugated Morpholinos for Management of The Huanglongbing Pathosystem.

  2020cites this paper
• TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

  2020cites this paper
• TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes

  2019cites this paper
• Antiviral Activity of a New Class of Chemically Modified Antisense Oligonucleotides against Influenza А Virus

  2019cites this paper
• Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening.

  2019cites this paper
• Safety, tolerability, and pharmacokinetics of radavirsen (AVI‐7100), an antisense oligonucleotide targeting influenza a M1/M2 translation

  2018cites this paper
• The Threat from Viruses

  2018cites this paper
• Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections

  2018cites this paper
• Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds

  2018cites this paper
• Intranasal Delivery of Peptide-Morpholinos to Knockdown Influenza Host Factors in Mice.

  2017cites this paper
• Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma

  2017cites this paper
• Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication

  2016cites this paper
• Nanoparticle-Mediated Nonviral DNA Delivery for Effective Inhibition of Influenza a Viruses in Cells

  2016cites this paper
• Morpholino antisense oligo inhibits trans-splicing of pre-inositol 1,4,5-trisphosphate receptor mRNA of Trypanosoma cruzi and suppresses parasite growth and infectivity.

  2016cites this paper
• Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques

  2016cites this paper
• Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance

  2016cites this paper
• High antiviral effect of TiO2·PL–DNA nanocomposites targeted to conservative regions of (−)RNA and (+)RNA of influenza A virus in cell culture

  2016cites this paper
• Antiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine Models

  2015cites this paper
• Taming Influenza Virus: Role of Antisense Technology.

  2015cites this paper
• Mammalian models for the study of H7 virus pathogenesis and transmission.

  2014cites this paper
• In vivo delivery of morpholino oligos by cell-penetrating peptides.

  2013cites this paper
• Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections

  2012cites this paper
• Two mutations in the C-terminal domain of influenza virus RNA polymerase PB2 enhance transcription by enhancing cap-1 RNA binding activity.

  2012cites this paper
• Advanced morpholino oligomers: A novel approach to antiviral therapy

  2012cites this paper
• RNA therapeutics: beyond RNA interference and antisense oligonucleotides

  2012cites this paper
• Title : In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides

  2012cites this paper
• Inhibition of porcine reproductive and respiratory syndrome virus infection in piglets by a peptide-conjugated morpholino oligomer.

  2011cites this paper
• Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides.

  2011cites this paper
• Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.

  2011cites this paper
• Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2

  2010cites this paper
• Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza.

  2010cites this paper
• Antiviral strategies to control calicivirus infections

  2010cites this paper
• Immunopathology and Infectious Diseases Spread of Infection and Lymphocyte Depletion in Mice Depends on Polymerase of Influenza Virus

  2010cites this paper
• Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

  2010cites this paper
• Limited Compatibility of Polymerase Subunit Interactions in Influenza A and B Viruses*

  2010cites this paper
• Cell-Penetrating Peptides for Antiviral Drug Development

  2010influential citation
• Chemical Modification of Oligonucleotides for Therapeutic, Bioanalytical and other Applications

  2009cites this paper
• Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.

  2009cites this paper
• Title : Investigation of Cis-acting RNA Element Role in Bovine Viral Diarrhea Virus Replication

  2009cites this paper
• Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

  2009influential citation
• A single substitution in amino acid 184 of the NP protein alters the replication and pathogenicity of H5N1 avian influenza viruses in chickens

  2009cites this paper
• Oligonucleotides derived from the packaging signal at the 5′ end of the viral PB2 segment specifically inhibit influenza virus in vitro

  2009cites this paper
• Morpholino oligomer-mediated protection of porcine pulmonary alveolar macrophages from arterivirus-induced cell death

  2009cites this paper
• Severe Acute Respiratory Syndrome Coronavirus Triggers Apoptosis via Protein Kinase R but Is Resistant to Its Antiviral Activity

  2008cites this paper
• Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.

  2008cites this paper
• Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus

  2008cites this paper